Note: Ingredients listed on restricted chemical lists
EC/CAS
232-674-9/9004-34-6
Name of the chemical
cellulose
Concentration
25.0-30.0
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
1.0-2.0
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
25.0-60.0
General Information
Revision date
2012-06-22
Product name
SB-742457 15MG AND 35MG TABLETS
Product Synonyms
None
1.2.1 Relevant identified uses
Investigational Medicinal Product
Emergency telephone
TRANSPORT EMERGENCIES (by country / geographic region
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
Section 2
EU Classification
Directive 67/548/EEC or 1999/45/EC as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device. Regulation (EC) No 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
Supplemental label elements
Not applicable
2.3 Other hazards
Expected to be non-combustible. Caution - Pharmaceutical agent. Not expected to be a significant health hazard unless product is crushed or broken. No information is available about the potential of this material to produce adverse environmental effects.
